Abstract:OBJECTIVE:To evaluate the clinical therapeutic effect of the combination therapy of traditional Chinese and Western medicines in treating gouty arthritis based on the stage of disease, and to explore a safe, effective and reasonable therapeutic regimen for prevention and treatment of gouty arthritis.METHODS:One hundred and sixty-six cases of gouty arthritis were divided into three groups randomly, 58 cases in traditional Chinese drug (TCD)-treated group, 56 cases in Western medicine (WM)-treated group and 52 cases in TCD plus WM-treated group. They were all treated for 12 weeks. In the acute stage, patients in TCD-treated group were treated with Huzhang Gout Granule and Jinhuang Ointment, and patients in WM-treated group were treated with diclofenac sodium dual release enteric-coated capsules. In the intermission, patients in TCD-treated group were given Yinlian Gout Granule, and patients in WM-treated group were given benzbromarone or allopurinol. Patients in TCD plus WM-treated group were given both TCD and WM. Clinical symptom score and blood uric acid (BUA) level were measured. The effect initiating time, relapse rate, efficacy rate and the incidence rate of adverse effects were also studied.RESULTS:There were no significant differences in the efficacy rate and effect initiating time among the three groups in the acute stage. The clinical symptom score and BUA level were obviously reduced in three groups. In the intermission, BUA level in the WM-treated group and TCD plus WM-treated group were obviously reduced. Although there was a drop tendency in the BUA level in TCD-treated group, there was no statistical difference. The relapse rates in TCD-, WM- and TCD plus WM-treated groups were 12.07%, 26.79% and 9.62%, respectively. There was statistical difference in relapse rates among the three groups (P<0.05). The relapse rate was decreased in TCD plus WM-treated group as compared with those in TCD-treated and WM-treated groups. The average clinical symptom scores during recurrence in the three groups were (10.00+/-3.61), (12.38+/-1.85) and (10.75+/-1.89), respectively. The incidence of adverse effects in TCD-treated group (3.45%) was lower than the other two groups (21.43% and 15.38%).CONCLUSION:The combination therapy of traditional Chinese and Western medicines based on the stage of disease can control the symptoms of gouty arthritis in the acute stage, improve joint function, and can control the BUA level during the intermission, prevent recurrence and relieve the adverse effects.

Treatment of Uric Acid Nephropathy with Integrated Traditional Chinese and Western Medicine

Effect of integrated Traditional Chinese and Western Medicine on Gout

Progress in Treatment of Gout Using Chinese and Western Medicine

Traditional Chinese herbs and natural products in hyperuricemia-induced chronic kidney disease

The potential of Chinese medicines in the treatment of hyperuricemia

[Clinical study of treatment on chronic uric acid nephropathy by integrating Western and traditional Chinese medicine]

[Modern understanding of uric acid metabolism disorders and progress in traditional Chinese medicine prevention and treatment]

Beneficial Properties and Mechanisms of Natural Phytochemicals to Combat and Prevent Hyperuricemia and Gout

Chinese Multidisciplinary Expert Consensus on the Diagnosis and Treatment of Hyperuricemia and Related Diseases

Research progress of treating hyperuricemia in rats and mice with traditional Chinese medicine

Signaling pathways in uric acid homeostasis and gout: From pathogenesis to therapeutic interventions

Nursing perspective of Guidelines for Diagnosis and Treatment of Gout with Integrated Traditional Chinese and Western Medicine

Traditional Chinese Herbal Medicine Plays a Role in the Liver, Kidney, and Intestine to Ameliorate Hyperuricemia according to Experimental Studies

Stage-based Treatment of Gouty Arthritis by Combination Therapy of Traditional Chinese and Western Medicines: a Randomized Controlled Trial

Traditional Chinese medicine in the treatment of patients with hyperuricemia: A randomized placebo‐controlled double‐blinded clinical trial

Hyperuricemia research progress in model construction and traditional Chinese medicine interventions

Research progress on the prevention and treatment of hyperuricemia by medicinal and edible plants and its bioactive components

Advances in Experimental and Clinical Research of the Gouty Arthritis Treatment with Traditional Chinese Medicine

Diagnosis and treatment of asymptomatic hyperuricemia

Treatment of gouty arthritis with traditional Chinese medicine decoction: Meta-analysis, network pharmacology analysis, and molecular docking

Original Article Hypouricemic and Nephroprotective Effects of Jianpi Huashi Decoction in a Rat Model of Hyperuricemia